Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders.

@article{Bridler2015PsychopharmacologicalTO,
  title={Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders.},
  author={Ren{\'e} Bridler and Anne Haeberle and Sabrina T M{\"u}ller and Katja Cattapan and Renate Grohmann and Sermin Toto and Siegfried Kasper and Waldemar Greil},
  journal={European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology},
  year={2015},
  volume={25 6},
  pages={763-72}
}
Patients with borderline personality disorder (BPD) are usually prescribed a variety of psychotropic drugs; however, none is recommended in the guidelines nor has any been approved for this indication. As data on drug prescriptions for BPD are sparse, cross-sectional data from the European Drug Safety Project AMSP were used to analyse drug prescriptions of 2195 in-patients with BPD between 2001 and 2011, and the mean values, confidence intervals and regression analyses were calculated. 70% of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS